FTC sues key pharmacy advantage managers over insulin price ranges The company introduced action towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of daily life-conserving insulin medicines. Don't skip tomorrow's healthcare sector news Enable Healthcare Dive's free newsletter maintain https://aya-healthcare-address00504.blogocial.com/everything-about-healthcare-news-66613666